
Sign up to save your podcasts
Or


The JournalFeed podcast for the week of July 21-25, 2025.
These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.
Monday Spoon Feed:
Novel blood-based biomarkers, specifically GFAP, UCH-L1, S100B, and NfL, may be well suited for early classification and triage of patients with acute and subacute minor traumatic brain injury.
Tuesday Spoon Feed:
To reduce hospitalizations of patients with mild to moderate COVID, treat with nirmatrelvir-ritonavir (Paxlovid) or remdesivir. To shorten the duration of COVID symptoms, azithroycin, favipiravir, molnupiravir, umifenovir, or corticosteroids may help, but they are not standard of care.
By Nick Zelt5
1919 ratings
The JournalFeed podcast for the week of July 21-25, 2025.
These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.
Monday Spoon Feed:
Novel blood-based biomarkers, specifically GFAP, UCH-L1, S100B, and NfL, may be well suited for early classification and triage of patients with acute and subacute minor traumatic brain injury.
Tuesday Spoon Feed:
To reduce hospitalizations of patients with mild to moderate COVID, treat with nirmatrelvir-ritonavir (Paxlovid) or remdesivir. To shorten the duration of COVID symptoms, azithroycin, favipiravir, molnupiravir, umifenovir, or corticosteroids may help, but they are not standard of care.

43,926 Listeners

32,106 Listeners

63,941 Listeners

1,868 Listeners

545 Listeners

275 Listeners

508 Listeners

259 Listeners

162 Listeners

59,108 Listeners

87,542 Listeners

112,063 Listeners

269 Listeners

56,553 Listeners

270 Listeners